HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by van Trommel, N. E Articles by Thomas, C. M G Search for Related Content PubMed PubMed Citation Articles by van Trommel, N. E Articles by Thomas, C. M G

Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG - and ß-subunits, and their ratios

¹ Departments of Chemical Endocrinology and ² Obstetrics and Gynecology, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands

(Correspondence should be addressed to C M G Thomas at Department of Chemical Endocrinology; Email: C.Thomas{at}ace.umcn.nl)

Objective: Human chorionic gonadotropin (hCG) is widely used in the management of hydatidiform mole and persistent trophoblastic disease (PTD). Predicting PTD after molar pregnancy might be beneficial since prophylactic chemotherapy reduces the incidence of PTD.

Design: A retrospective study based on blood specimens collected in the Dutch Registry for Hydatidiform Moles. A group of 165 patients with complete moles (of which 43 had PTD) and 39 patients with partial moles (of which 7 had PTD) were compared with 27 pregnant women with uneventful pregnancy.

Methods: Serum samples from patients with hydatidiform mole with or without PTD were assayed using specific (radio) immunoassays for free -subunit (hCG), free ß-subunit (hCGß) and ‘total’ hCG (hCG + hCGß). In addition, we calculated the ratios hCG/hCG + hCGß, hCGß/hCG + hCGß, and hCG/hCGß. Specificity and sensitivity were calculated and paired in receiver-operating characteristic (ROC) curve analysis, resulting in areas under the curves (AUCs).

Results: hCGß, hCGß/hCG + hCGß and hCG/hCGß show AUCs ranging between 0.922 and 0.999 and, therefore, are excellent diagnostic tests to distinguish complete and partial moles from normal pregnancy. To distinguish partial from complete moles the analytes hCGß, hCG + hCGß and the ratio hCG/hCGß have AUCs between 0.7 and 0.8. Although hCG, hCGß and hCG + hCGß concentrations are significantly elevated in patients who will develop PTD compared with patients with spontaneous regression after evacuation of their moles, in predicting PTD, these analytes and parameters have AUCs <0.7.

Conclusions: Distinction between hydatidiform mole and normal pregnancy is best shown by a single blood specimen with hCGß, but hCGß/hCG + hCGß and hCG/hCGß are also excellent diagnostic parameters. To predict PTD, hCG, hCGß, hCG + hCGß and hCG/hCGß are moderately accurate tests, although they are not accurate enough to justify prophylactic chemotherapy treatment for prevention of PTD.

This article has been cited by other articles:

				S.F. de Medeiros and R.J. Norman Human choriogonadotrophin protein core and sugar branches heterogeneity: basic and clinical insights Hum. Reprod. Update, January 1, 2009; 15(1): 69 - 95. [Abstract] [Full Text] [PDF]

				Z. Cao and R. Rej Are Laboratories Reporting Serum Quantitative hCG Results Correctly? Clin. Chem., April 1, 2008; 54(4): 761 - 764. [Abstract] [Full Text] [PDF]